{
    "SPADE_N_13724": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13724",
            "Peptide Name": "BM1122 (natural AMPs; Bacteriocin, Gram-positive bacteria, prokaryotes, UCLL1)",
            "Source": "culture supernatant,Lactobacillus crustorumMN047",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "MANKAELIDVASKTGLTKKDATSAVDAVFETIQENLSEGNKVQLIGFGNFEVRQRAARKGRNPQTGEEIKIPASKVPAFKPGKALKDSVK",
            "Sequence Length": 90,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 9683.97,
            "PI": 9.7,
            "Hydrophobicity": -0.53,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Yi L, Luo L, LÃ¼ X.2018",
                    "Reference": "Front Microbiol. 2018 Jul 13;9:1567. doi: 10.3389/fmicb.2018.01567PubMed",
                    "Title": "Efficient Exploitation of Multiple Novel Bacteriocins by Combination of Complete Genome and Peptidome."
                }
            ],
            "Frequent Amino Acids": "KAE",
            "Absent Amino Acids": "CHOUWY",
            "Basic Residues": 16,
            "Acidic Residues": 11,
            "Hydrophobic Residues": 37,
            "Polar Residues": 53,
            "Positive Residues": 16,
            "Negative Residues": 11,
            "Net Charge": 5,
            "Comments": "Sequence analysis: APD analysis reveals this sequence is most similar (32.41%) tohuman HMGN2GRAVY: -0.53; Mol formula: C425H712N118O132S1; M. Wt:  9684.073; molar extinction coefficient: 0.Activity:   Diffusion zone assay: active against Gram+ S. aureus ATCC 29213, 25923 (23.1-24.4 mm), E. faecalis ATCC 29212 (12.9 mm), L. monocytogenes CMCC 54004 (21.7 mm), resistant S. aureus 1 (13.2 mm), 3 (10.6 mm) and 4 (11.6), Gram- E. coli ATCC 25922 (20.9 mm), Salmonella CMCC 50071 (27.3 mm), C. sakazakii ATCC 29544 (22.7 mm), also active against antibiotic-resistant C. sakazakii (21.5-23.5 mm) and Salmonella 557D (22 mm). In addition, the MIC of this peptide was measured to be 13.7 ug/ml against S. aureus ATCC 29213 and E. coli ATCC 25922. Reg. 11/2021",
            "Similar Sequences": []
        }
    }
}